๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex

Book ID
122203386
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
170 KB
Volume
5
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Killing lung cancer cells at cell-cycle
Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex
โœ De-Yan Hou; Jose V. Ordonez; Richard J. Cross; Douglas D. Ross; Yosh Maruyama ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 489 KB

The efficacy of killing small cell lung cancer (SCLC) cells at the G I , S, and G2-M phase of the cell-cycle by a new "'In-bleomycin complex (' ' 'In-BLMC) was investigated. SCLC cells (N417, H526, H209) were synchronized by double thymidine block and assessed by DNA content with flow cytometry, and

Enhanced killing of human small cell lun
Enhanced killing of human small cell lung cancer by hyperthermia and lndium-111- bleomycin complex
โœ De-Yan Hou; And Yosh Maruyama ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 382 KB

Indium-1 1 1 -bleomycin complex (' ' In-BLMC) is a radiopharmaceutical agent that produces tumor regression in mouse glioma in vivo and kills human small cell lung cancer (SCLC) cells in vitro. The interaction between hyperthermia and ' ' 'In-BLMC against human SCLC (N417) cells was studied for bleo

Sequential treatment with vindesineโ€“ifos
Sequential treatment with vindesineโ€“ifosfamideโ€“platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial1Data presented in part at the 61st Annual International Scientific Assembly of the American College of Chest Physicians, New York, NY, USA, 31 October 1995.1
โœ Van den Brande, P; De Ruysscher, D; Vansteenkiste, J; Spaas, Ph; Specenier, P; D ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 93 KB